PSYCH OpenIR  > 健康与遗传心理学研究室
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action
Yuan, Kai1; Zheng, Yong-Bo1,2; Wang, Yi-Jie2; Sun, Yan-Kun1; Gong, Yi-Miao1; Huang, Yue-Tong1; Chen, Xuan3; Liu, Xiao-Xing1; Zhong, Yi1,2; Su, Si-Zhen1; Gao, Nan3; Lu, Yi-Long4; Wang, Zhe1; Liu, Wei-Jian1; Que, Jian-Yu1; Yang, Ying-Bo3; Zhang, An-Yi1; Jing, Meng-Ni5; Yuan, Chen-Wei6; Zeng, Na7,8,9,10; Vitiello, Michael V.11; Patel, Vikram12; Fazel, Seena13; Minas, Harry14; Thornicroft, Graham15,16; Fan, Teng-Teng1; Lin, Xiao1; Yan, Wei1; Shi, Le1; Shi, Jie7,8; Kosten, Thomas17; Bao, Yan-Ping7,8,9; Lu, Lin1,2,7,8
第一作者Kai Yuan
通讯作者邮箱kosten@bcm.edu ; baoyp@bjmu.edu.cn ; linlu@bjmu.edu.cn
心理所单位排序6
摘要

Infectious disease epidemics have become more frequent and more complex during the 21(st) century, posing a health threat to the general public and leading to psychological symptoms. The current study was designed to investigate the prevalence of and risk factors associated with depression, anxiety and insomnia symptoms during epidemic outbreaks, including COVID-19. We systematically searched the PubMed, Embase, Web of Science, OVID, Medline, Cochrane databases, bioRxiv and medRxiv to identify studies that reported the prevalence of depression, anxiety or insomnia during infectious disease epidemics, up to August 14(th), 2020. Prevalence of mental symptoms among different populations including the general public, health workers, university students, older adults, infected patients, survivors of infection, and pregnant women across all types of epidemics was pooled. In addition, prevalence of mental symptoms during COVID-19 was estimated by time using meta-regression analysis. A total of 17,506 papers were initially retrieved, and a final of 283 studies met the inclusion criteria, representing a total of 948,882 individuals. The pooled prevalence of depression ranged from 23.1%, 95% confidential intervals (95% CI: [13.9-32.2]) in survivors to 43.3% (95% CI: [27.1-59.6]) in university students, the pooled prevalence of anxiety ranged from 25.0% (95% CI: [12.0-38.0]) in older adults to 43.3% (95% CI: [23.3-63.3]) in pregnant women, and insomnia symptoms ranged from 29.7% (95% CI: [24.4-34.9]) in the general public to 58.4% (95% CI: [28.1-88.6]) in university students. Prevalence of moderate-to-severe mental symptoms was lower but had substantial variation across different populations. The prevalence of mental problems increased over time during the COVID-19 pandemic among the general public, health workers and university students, and decreased among infected patients. Factors associated with increased prevalence for all three mental health symptoms included female sex, and having physical disorders, psychiatric disorders, COVID infection, colleagues or family members infected, experience of frontline work, close contact with infected patients, high exposure risk, quarantine experience and high concern about epidemics. Frequent exercise and good social support were associated with lower risk for these three mental symptoms. In conclusion, mental symptoms are common during epidemics with substantial variation across populations. The population-specific psychological crisis management are needed to decrease the burden of psychological problem and improve the mental wellbeing during epidemic.

2022-06-06
语种英语
DOI10.1038/s41380-022-01638-z
发表期刊MOLECULAR PSYCHIATRY
ISSN1359-4184
页码9
期刊论文类型实证研究
收录类别SCI
资助项目National Key Research and Development Program of China[2021YFC0863700] ; National Key Research and Development Program of China[2019YFA0706200] ; National Key Research and Development Program of China[2019YFC0118502] ; National Natural Science Foundation of China[81761128036] ; National Natural Science Foundation of China[81821092] ; National Natural Science Foundation of China[82171514] ; National Natural Science Foundation of China[82001404] ; National Natural Science Foundation of China[81901345] ; PKU-Baidu Fund[2020BD011]
出版者SPRINGERNATURE
WOS关键词MENTAL-HEALTH-CARE ; POSTTRAUMATIC-STRESS ; MEDICAL WORKERS ; CHINA ; EPIDEMIC ; SURVIVORS ; OUTBREAK ; IMPACT
WOS研究方向Biochemistry & Molecular Biology ; Neurosciences & Neurology ; Psychiatry
WOS类目Biochemistry & Molecular Biology ; Neurosciences ; Psychiatry
WOS记录号WOS:000806685800004
WOS分区Q1
资助机构National Key Research and Development Program of China ; National Natural Science Foundation of China ; PKU-Baidu Fund
引用统计
被引频次:97[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.psych.ac.cn/handle/311026/42772
专题健康与遗传心理学研究室
通讯作者Kosten, Thomas; Bao, Yan-Ping; Lu, Lin
作者单位1.Peking Univ, Natl Clin Res Ctr Mental Disorders, Peking Univ Sixth Hosp,Res Unit 2018RU006, Inst Mental Hlth,NHC Key Lab Mental Hlth,Chinese, Beijing, Peoples R China
2.Peking Univ, McGovern Inst Brain Res, Peking Tsinghua Ctr Life Sci & PKU IDG, Beijing, Peoples R China
3.Xinxiang Med Univ, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China
4.Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China
5.Renmin Univ China, Dept Psychol, Beijing, Peoples R China
6.Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China
7.Peking Univ, Natl Inst Drug Dependence, Beijing, Peoples R China
8.Peking Univ, Beijing Key Lab Drug Dependence, Beijing, Peoples R China
9.Peking Univ, Sch Publ Hlth, Beijing, Peoples R China
10.Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
11.Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
12.Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA
13.Univ Oxford, Dept Psychiat, Oxford, England
14.Univ Melbourne, Ctr Mental Hlth, Sch Populat & Global Hlth, Global & Cultural Mental Hlth Unit, Melbourne, Vic, Australia
15.Kings Coll London, Ctr Global Mental Hlth, Inst Psychiat Psychol & Neurosci, London, England
16.Kings Coll London, Ctr Implementat Sci, Inst Psychiat Psychol & Neurosci, London, England
17.Baylor Coll Med, Dept Psychiat Pharmacol Neurosci Immunol, Houston, TX 77030 USA
推荐引用方式
GB/T 7714
Yuan, Kai,Zheng, Yong-Bo,Wang, Yi-Jie,et al. A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action[J]. MOLECULAR PSYCHIATRY,2022:9.
APA Yuan, Kai.,Zheng, Yong-Bo.,Wang, Yi-Jie.,Sun, Yan-Kun.,Gong, Yi-Miao.,...&Lu, Lin.(2022).A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action.MOLECULAR PSYCHIATRY,9.
MLA Yuan, Kai,et al."A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to action".MOLECULAR PSYCHIATRY (2022):9.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
A systematic review (1283KB)期刊论文出版稿限制开放CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yuan, Kai]的文章
[Zheng, Yong-Bo]的文章
[Wang, Yi-Jie]的文章
百度学术
百度学术中相似的文章
[Yuan, Kai]的文章
[Zheng, Yong-Bo]的文章
[Wang, Yi-Jie]的文章
必应学术
必应学术中相似的文章
[Yuan, Kai]的文章
[Zheng, Yong-Bo]的文章
[Wang, Yi-Jie]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。